Research programme: anabolic musculoskeletal therapeutics - Vibe PharmaceuticalsAlternative Names: VB-102
Latest Information Update: 11 Aug 2016
At a glance
- Originator University of Pennsylvania
- Developer Vibe Pharmaceuticals
- Class Proteins
- Mechanism of Action Bone development stimulants; Osteogenesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Muscular atrophy; Osteoporosis